Transition Bio

Transition Bio is leveraging the expertise of world leaders in microfluidics, cell imaging, and machine learning to establish the Condensomics™ platform to revolutionize biomolecular condensate-focused drug discovery. The unique platform uses droplet microfluidics to drive high-throughput generation of proprietary data and machine learning-guided target identification to enable the discovery of new therapies for intractable diseases.